Back to results
US 2025/0027071 A1Published application
Novel lipocalin-type prostaglandin d synthase (l-pgds) mutant and uses thereof
AssigneesNanyang Technological University, Singapore Health Services Pte Ltd
InventorsKonstantin Pervushin, Jia Yi Kimberly Low, Jodhbir Singh Mehta, Bhargy Sharma
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the pharmaceutical field. Specifically, the present disclosure relates to a novel Lipocalin-type prostaglandin D synthase (L-PGDS) mutant (RA L-PGDS) as well as its use in the treatment of amyloid-related diseases.
Claims18
An isolated Lipocalin-type prostaglandin D synthase (L-PGDS) polypeptide mutant consisting of the amino acid sequence set forth in SEQ ID NO:
- 5.
Dependencies are inferred from the claim text.